.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Accurately evaluating the effects of rectal cancer neoadjuvant therapy is vital for optimizing surgical and oncological management. Although clinicians use advanced imaging and physical exams to gauge response, these clinical assessments often differ from final pathologic findings. Consequently, understanding this discordance helps medical teams manage expectations and refine long-term care plans.
Researchers recently analyzed 180 patients with locally advanced rectal cancer to compare clinical and pathologic responses. The study found that clinical evaluations suggested a complete or near-complete response in nearly half of the participants. However, pathologic examination confirmed this high response level in only 35% of the cases. This moderate concordance indicates that clinical tools frequently overestimate the actual degree of tumor regression. For instance, discordance occurred in over 28% of patients, mostly due to clinical overestimation of the treatment effect. Furthermore, the study demonstrated that pathologic response is a much stronger predictor of survival. Patients achieving a pathologic complete response showed a 3-year disease-free survival rate of 89.2%. In contrast, those without such a response had a rate of only 69.1%. Interestingly, clinical response status alone did not significantly correlate with overall survival or disease-free survival outcomes.
Clinical assessments rely on imaging and exams that may miss microscopic residual disease. Pathologic response is determined by a microscopic examination of the entire resected specimen, which is more accurate.
While not strictly necessary, achieving a pathologic complete response is strongly associated with significantly improved disease-free and overall survival rates compared to incomplete responses.
No, because clinical response can overestimate the treatment effect. Pathologic verification remains the gold standard for predicting long-term outcomes and guiding further therapy.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research shows clinical response often overestimates pathologic outcomes in rectal cancer, highlighting pCR as the primary predictor of survival....
5 months ago
A retrospective cohort study of 7,716 ICU patients from the MIMIC-IV database demonstrates that Gradient Boosting Decision Trees significantly outperform traditional SOFA scores in predicting in-hospital mortality among patients with sepsis and diabetes, with SHAP analysis providing clinical interpretability.
Today
Occult maternal malignancy accounts for 3.82% of persistent unreportable NIPT results with genomic noise. Multiple chromosomal aberrations, notably on chromosome 18, warrant thorough oncological evaluation and whole-body MRI to ensure timely maternal diagnosis while preserving fetal care.
Today
This article reviews the forensic and clinical complexities of acute myocarditis arising on left ventricular hypertrophy in children, highlighting early diagnostic red flags and multidisciplinary postmortem autopsy protocols.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday
